Boston Scientific Corporation (BSX)

Boston Scientific Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	20,074	16,747	14,240	12,682	11,888
Revenue Growth (YoY)	19.87%	17.61%	12.29%	6.68%	19.92%
Cost of Revenue	5,975	5,290	4,391	4,003	3,760
Gross Profit	14,099	11,457	9,849	8,679	8,128
Selling, General & Admin	6,887	5,984	5,190	4,520	4,359
Research & Development	2,052	1,615	1,414	1,323	1,204
Amortization of Goodwill & Intangibles	897	856	828	803	741
Operating Expenses	9,836	8,455	7,432	6,646	6,304
Operating Income	4,263	3,002	2,417	2,033	1,824
Interest Expense	-349	-305	-265	-470	-341
Interest & Investment Income	-	107	22	10	4
Currency Exchange Gain (Loss)	-	-16	-41	-31	-27
Other Non Operating Income (Expenses)	-81	-30	-15	-14	-7
EBT Excluding Unusual Items	3,833	2,758	2,118	1,528	1,453
Merger & Restructuring Charges	-164	-16	-69	-24	-40
Gain (Loss) on Sale of Investments	-26	-79	-59	-1	250
Gain (Loss) on Sale of Assets	-	-	-	-22	78
Asset Writedown	-46	-386	-58	-132	-370
Legal Settlements	-194	-	111	-173	-430
Other Unusual Items	-18	5	-58	-35	136
Pretax Income	3,385	2,282	1,985	1,141	1,077
Income Tax Expense	493	436	393	443	36
Earnings From Continuing Operations	2,892	1,846	1,592	698	1,041
Minority Interest in Earnings	6	8	1	-	-
Net Income	2,898	1,854	1,593	698	1,041
Preferred Dividends & Other Adjustments	-	1	23	56	56
Net Income to Common	2,898	1,853	1,570	642	985
Net Income Growth	56.31%	16.38%	128.22%	-32.95%	-
Shares Outstanding (Basic)	1,480	1,472	1,453	1,431	1,422
Shares Outstanding (Diluted)	1,495	1,486	1,464	1,440	1,434
Shares Change (YoY)	0.58%	1.53%	1.65%	0.41%	1.21%
EPS (Basic)	1.96	1.26	1.08	0.45	0.69
EPS (Diluted)	1.94	1.25	1.07	0.45	0.69
EPS Growth	55.20%	16.82%	138.42%	-34.96%	-
Free Cash Flow	-	2,645	1,792	938	1,316
Free Cash Flow Per Share	-	1.78	1.22	0.65	0.92
Gross Margin	70.23%	68.41%	69.16%	68.44%	68.37%
Operating Margin	21.24%	17.93%	16.97%	16.03%	15.34%
Profit Margin	14.44%	11.06%	11.03%	5.06%	8.29%
Free Cash Flow Margin	-	15.79%	12.58%	7.40%	11.07%
EBITDA	5,600	4,271	3,613	3,169	2,917
EBITDA Margin	27.90%	25.50%	25.37%	24.99%	24.54%
D&A For EBITDA	1,337	1,269	1,196	1,136	1,093
EBIT	4,263	3,002	2,417	2,033	1,824
EBIT Margin	21.24%	17.93%	16.97%	16.03%	15.34%
Effective Tax Rate	14.56%	19.11%	19.80%	38.82%	3.34%

Updated Feb 4, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q